Osaka, Japan

Yasutaka Ikeda

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasutaka Ikeda: Innovator in Health and Wellness

Introduction

Yasutaka Ikeda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of health and wellness through his innovative research and development. His work focuses on improving physical activity efficiency and reducing fatigue, which has implications for various applications in health and fitness.

Latest Patents

Yasutaka Ikeda holds a patent for a composition containing kaempferol analogs. This patent outlines a method for enhancing physical activity efficiency, reducing fatigue, and improving dynamic and kinetic visual acuity. The composition is designed to be administered to individuals in need of these benefits, showcasing Ikeda's commitment to advancing health solutions.

Career Highlights

Ikeda is associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate and develop new health-related products. His work at Otsuka has allowed him to collaborate with other experts in the field and contribute to the company's mission of improving health and well-being.

Collaborations

Some of his notable coworkers include Ayuko Oyama and Yasuhiro Abiru. Their collaborative efforts have further enhanced the research and development initiatives at Otsuka Pharmaceutical Company.

Conclusion

Yasutaka Ikeda's contributions to health and wellness through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to impact the lives of many individuals seeking to improve their physical health and performance.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…